Nav: Home

Ten Reaxys® Ph.D. prize candidates selected to present at symposium in London

August 04, 2016

Philadelphia, PA, August 4, 2016 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that 10 Reaxys PhD Prize candidates have been short-listed from the 45 chemists nominated in May. The candidates will present at the annual Reaxys Prize Symposium to be held in conjunction with the New Scientist Live festival in London from September 22-23.

The oral presentation in September will be the last step in the reviewing process of the Reaxys PhD Prize, an international award that recognizes and rewards the most innovative research produced by chemistry's rising stars. The jury, which consists of members of the Reaxys Advisory Board, will chose three winners, who will be announced at the Symposium dinner on September 23.

The 10 shortlisted candidates are:
  • Nickolas Anderson from the Bart group, Purdue University - West Lafayette
  • Chuyang Cheng from the Stoddart group, Northwestern University
  • Lauren Doyle from the Piers group, University of Calgary
  • Pascal Ellerbrock from the Trauner group, Ludwig-Maximilian University of Munich
  • Sebastian Grundner from the Lercher group, Technical University of Munich
  • Jamie Hicks from the Jones group, Monash University
  • Jiheong Kang from the Aida group, University of Tokyo
  • Jarad Mason from the Long group, University of California Berkeley
  • Yusuke Masuda from the Murakami group, Kyoto University
  • Alison Wendlandt from the Stahl group, University of Wisconsin - Madison


All of the original 45 finalists from this year's prize have been invited to attend the Symposium and present their work during a poster session. The jury's review criteria include the originality, innovation, applicability, importance, and rigor of the reported research.

Since its introduction in 2010, the Reaxys PhD Prize has received more than 3,000 submissions, from nearly 650 universities worldwide. The Prize aims to not only nurture advances in chemistry by giving talented young chemists who have produced groundbreaking research the recognition they deserve, but also present them with opportunities to extend their network, unlock new sources of inspiration and share knowledge.

Read more about the Reaxys PhD Prize, this year's 10 short-listed candidates and the Symposium.
-end-
About Reaxys

Reaxys empowers chemistry research and development by providing structure, property and reaction data, experimental procedures and literature. It is designed to support early drug discovery, education, material selection and synthesis planning; its capabilities include data export and integration to enable harmonized analysis of in-house and external data. Reaxys improves R&D productivity by delivering the facts the way chemists need them. http://www.elsevier.com/reaxys

Reaxys is a trademark of RELX Intellectual Properties SA, used under license.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries.

http://www.elsevier.com

Elsevier

Related Candidates Articles:

Kidneys from diabetic donors may benefit many transplant candidates
Patients who received kidney transplants from donors with diabetes had better survival compared with those who remained on the waitlist.
Potential drug candidates halt prostate and breast cancer growth
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have designed two new drug candidates to target prostate and triple negative breast cancers.
Transgender political candidates still likely face an uphill battle, study finds
A new study led by a University of Kansas political scientist found 35 percent-40 percent of adults would oppose a transgender candidate for office, which was higher than the 30 percent who would likely oppose a gay or lesbian candidate.
Differences in the rhetorical styles of candidates in the 2016 US presidential election
A new paper published in Digital Scholarship in the Humanities reveals and quantifies dramatic differences in the speaking styles of candidates in the 2016 United States presidential election.
Study finds that views of swing voters do not matter much to presidential candidates
Despite the familiar belief that candidates must appeal to the 'moderate middle' of the voting public in order to win elections, US presidential candidates routinely take less-than moderate positions on a variety of issues.
Vaccine candidates protect primates against Zika virus
A month after announcing that two promising vaccine candidates provided mice with complete protection against the Zika virus, a research team at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR) and the University of São Paulo, now reports achieving complete protection against Zika virus in rhesus monkeys.
Vaccine candidates protect against Zika virus in rhesus monkeys
An Army-developed ZIKV purified inactivated virus Zika vaccine candidate provided robust protection against the virus in rhesus monkeys in a new preclinical study.
Team led by SF State astronomer catalogs most likely 'second-Earth' candidates
An international team of researchers has pinpointed which of the more than 4,000 exoplanets discovered by NASA's Kepler mission are most likely to be similar to Earth.
Americans say political candidates are not listening to their health concerns
A strong majority of Americans (81 percent) say medicines available today have improved their quality of life and even more (91 percent) say it is important to develop better medicines for conditions we currently treat, according to a new national public opinion survey commissioned by Research!America.
Plant kingdom provides 2 new candidates for the war on antibiotic resistance
New research has discovered peptides from two crop species that have antimicrobial effects on bacteria implicated in food spoilage and food poisoning.

Related Candidates Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...